Weitere Artikel dieser Ausgabe durch Wischen aufrufen
Patient-reported outcomes (PROs) are an umbrella term covering a range of outcomes, including symptoms, functioning, health-related quality of life, and supportive care needs. Research regarding the appropriate PRO questionnaires to use is informative. A previously published latent class analysis (LCA) examined patterns of function, symptoms, and supportive care needs in a sample of US cancer patients. The current analysis investigated whether the findings from the original study were replicated in new samples from different countries and whether a larger sample combining all the data would affect the classes identified.
This secondary analysis of data from 408 Japanese and 189 Canadian cancer patients replicated the methods used in the original LCA using data from 117 US cancer patients. In all samples, subjects completed the EORTC-QLQ-C30 and Supportive Care Needs Survey Short Form-34 (SCNS-SF34). We first dichotomized individual function, symptom, and need domain scores. We then performed LCA to investigate the patterns of domains for each of the outcomes, both in the individual country samples and then combining the data from all three samples.
Across all analyses, class assignment was made by level of function, symptoms, or needs. In individual samples, only two-class models (“high” vs. “low”) were generally identifiable while in the combined sample, three-class models (“high” vs. “moderate” vs. “low”) best fit the data for all outcomes.
In this analysis, the level of burden experienced by patients was the key factor in defining classes.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Acquadro, C., Berzon, R., Dubois, D., Leidy, N. K., Marquis, P., Revicki, D., et al. (2003). Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the patient-reported outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value in Health,6(5), 522–531. PubMedCrossRef
U.S. Food and Drug Administration (2009). Guidance for industry: Patient reported outcome measures: Use in medical product development to support labeling claims.
Snyder, C. F., Dy, S. M., Hendricks, D. E., Brahmer, J. R., Carducci, M. A., Wolff, A. C., et al. (2007). Asking the right questions: investigating needs assessments and health-related quality-of-life questionnaires for use in oncology clinical practice. Supportive Care in Cancer,15(9), 1075–1085. PubMedCrossRef
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute,85(5), 365–376. PubMedCrossRef
Lanza, S. T., Bray, B. C., Collins, L. M. (2013). An introduction to latent class and latent transition analysis. In I. B. Weiner (Ed.), Handbook of psychology: Research methods in psychology (Second Edition, Vol. 2, pp. 691–716). Hoboken: John Wiley & Sons, Inc.
Fayers, P. M., Weeden, S., Curran, D., on behalf of the EORTC Quality of Life Study Group. (1998). EORTC reference values. Brussels: EORTC.
Dodd, M. J., Miaskowski, C., & Paul, S. M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum,28(3), 465–470. PubMed
Miaskowski, C., Dodd, M., Lee, K. (2004). Symptom clusters: The new frontier in symptom management research. Journal of the National Cancer Institute. Monographs (32), 17–21.
- Cancer patients’ function, symptoms and supportive care needs: a latent class analysis across cultures
Jennifer Barsky Reese
Claire F. Snyder
- Springer International Publishing
Neuer Inhalt/© Stellmach, Neuer Inhalt/© BBL, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta, Neuer Inhalt/© hww, Neuer Inhalt/© julien tromeur | Fotolia